Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks. The company's blood analysis technology measures various biomarkers from a single blood sample and identifies personal risks of disease using health data assets. It serves healthcare industry and researchers in Finland, the United Kingdom, rest of Europe, and internationally. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
Stock data | 2023 | Change |
---|---|---|
Price | $3.71 | N/A |
Market Cap | $145.35M | N/A |
Shares Outstanding | 39.15M | -35.00% |
Employees | 88.00 | N/A |
Shareholder Equity | 97.36M | -12.64% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 31.27 | N/A |
P/B Ratio | 1.49 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.2064 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $4.65M | N/A |
Earnings | -$20.10M | N/A |
Gross Margin | 0.8589 | N/A |
Operating Margin | -4.47 | N/A |
Net income margin | -4.32 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $118.70M | N/A |
Total Debt | $5.59M | N/A |
Cash on Hand | $89.63M | N/A |
Debt to Equity | 0.1077 | -14.32% |
Cash to Debt | $16.03 | 32.61% |
Current Ratio | $12.14 | -1.16% |